Literature DB >> 26482223

Minimal Clinically Important Difference in the Physical, Emotional, and Total Symptom Distress Scores of the Edmonton Symptom Assessment System.

David Hui1, Omar Shamieh2, Carlos Eduardo Paiva3, Odai Khamash2, Pedro Emilio Perez-Cruz4, Jung Hye Kwon5, Mary Ann Muckaden6, Minjeong Park7, Joseph Arthur8, Eduardo Bruera8.   

Abstract

CONTEXT: The Edmonton Symptom Assessment System (ESAS) is one of the most commonly used symptom batteries in clinical practice and research.
OBJECTIVES: We used the anchor-based approach to identify the minimal clinically important difference (MCID) for improvement and deterioration for ESAS physical, emotional, and total symptom distress scores.
METHODS: In this multicenter prospective study, we asked patients with advanced cancer to complete their ESAS at the first clinic visit and at a second visit three weeks later. The anchor for MCID determination was Patient's Global Impression regarding their physical, emotional, and overall symptom burden ("better," "about the same," or "worse"). We identified the optimal sensitivity/specificity cutoffs for both improvement and deterioration for the three ESAS scores and also determined the within-patient changes.
RESULTS: A total of 796 patients were enrolled from six centers. The ESAS scores had moderate responsiveness, with area under the receiver operating characteristic curve between 0.69 and 0.76. Using the sensitivity-specificity approach, the optimal cutoffs for ESAS physical, emotional, and total symptom distress scores were ≥3/60, ≥2/20, and ≥3/90 for improvement, and ≤-4/60, ≤-1/20, and ≤-4/90 for deterioration, respectively. These cutoffs had moderate sensitivities (59%-68%) and specificities (62%-80%). The within-patient change approach revealed the MCID cutoffs for improvement/deterioration to be 3/-4.3 for the physical score, 2.4/-1.8 for the emotional score, and 5.7/-2.9 for the total symptom distress score.
CONCLUSION: We identified the MCIDs for physical, emotional, and total symptom distress scores, which have implications for interpretation of symptom response in clinical trials.
Copyright © 2016 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Neoplasms; outcome measures; pain; sample size; sensitivity and specificity; symptom assessment

Mesh:

Year:  2015        PMID: 26482223      PMCID: PMC4733575          DOI: 10.1016/j.jpainsymman.2015.10.004

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  35 in total

Review 1.  Understanding the minimum clinically important difference: a review of concepts and methods.

Authors:  Anne G Copay; Brian R Subach; Steven D Glassman; David W Polly; Thomas C Schuler
Journal:  Spine J       Date:  2007-04-02       Impact factor: 4.166

Review 2.  The Edmonton Symptom Assessment System, a proposed tool for distress screening in cancer patients: development and refinement.

Authors:  Sharon M Watanabe; Cheryl L Nekolaichuk; Crystal Beaumont
Journal:  Psychooncology       Date:  2011-06-13       Impact factor: 3.894

3.  Capturing the patient's view of change as a clinical outcome measure.

Authors:  D Fischer; A L Stewart; D A Bloch; K Lorig; D Laurent; H Holman
Journal:  JAMA       Date:  1999 Sep 22-29       Impact factor: 56.272

Review 4.  Interpretation of quality of life changes.

Authors:  E Lydick; R S Epstein
Journal:  Qual Life Res       Date:  1993-06       Impact factor: 4.147

5.  Determining a minimal important change in a disease-specific Quality of Life Questionnaire.

Authors:  E F Juniper; G H Guyatt; A Willan; L E Griffith
Journal:  J Clin Epidemiol       Date:  1994-01       Impact factor: 6.437

6.  Symptom burden and performance status in a population-based cohort of ambulatory cancer patients.

Authors:  Lisa Barbera; Hsien Seow; Doris Howell; Rinku Sutradhar; Craig Earle; Ying Liu; Audra Stitt; Amna Husain; Jonathan Sussman; Deborah Dudgeon
Journal:  Cancer       Date:  2010-11-08       Impact factor: 6.860

7.  Minimal clinically important differences in the Edmonton Symptom Assessment Scale in cancer patients: A prospective, multicenter study.

Authors:  David Hui; Omar Shamieh; Carlos Eduardo Paiva; Pedro Emilio Perez-Cruz; Jung Hye Kwon; Mary Ann Muckaden; Minjeong Park; Sriram Yennu; Jung Hun Kang; Eduardo Bruera
Journal:  Cancer       Date:  2015-06-08       Impact factor: 6.860

8.  Cancer Care Ontario's experience with implementation of routine physical and psychological symptom distress screening.

Authors:  Deborah Dudgeon; Susan King; Doris Howell; Esther Green; Julie Gilbert; Erin Hughes; Brendon Lalonde; Helen Angus; Carol Sawka
Journal:  Psychooncology       Date:  2011-02-08       Impact factor: 3.894

9.  Predictors of symptom severity and response in patients with metastatic cancer.

Authors:  Camilla Zimmermann; Debika Burman; Matthew Follwell; Kristina Wakimoto; Dori Seccareccia; John Bryson; Lisa W Le; Gary Rodin
Journal:  Am J Hosp Palliat Care       Date:  2009-09-25       Impact factor: 2.500

10.  Global rating of change scales: a review of strengths and weaknesses and considerations for design.

Authors:  Steven J Kamper; Christopher G Maher; Grant Mackay
Journal:  J Man Manip Ther       Date:  2009
View more
  40 in total

1.  The Frailty Phenotype and Palliative Care Needs of Older Survivors of Critical Illness.

Authors:  Lauren R Pollack; Nathan E Goldstein; Wendy C Gonzalez; Craig D Blinderman; Mathew S Maurer; David J Lederer; Matthew R Baldwin
Journal:  J Am Geriatr Soc       Date:  2017-03-06       Impact factor: 5.562

Review 2.  The Edmonton Symptom Assessment System 25 Years Later: Past, Present, and Future Developments.

Authors:  David Hui; Eduardo Bruera
Journal:  J Pain Symptom Manage       Date:  2016-12-29       Impact factor: 3.612

Review 3.  Palliative Cancer Care in the Outpatient Setting: Which Model Works Best?

Authors:  David Hui
Journal:  Curr Treat Options Oncol       Date:  2019-02-11

4.  The effects of oncology massage on symptom self-report for cancer patients and their caregivers.

Authors:  Gabriel Lopez; Wenli Liu; Kathrin Milbury; Amy Spelman; Qi Wei; Eduardo Bruera; Lorenzo Cohen
Journal:  Support Care Cancer       Date:  2017-06-28       Impact factor: 3.603

5.  Associations Between Polypharmacy, Symptom Burden, and Quality of Life in Patients with Advanced, Life-Limiting Illness.

Authors:  Yael Schenker; Seo Young Park; Kwonho Jeong; Jennifer Pruskowski; Dio Kavalieratos; Judith Resick; Amy Abernethy; Jean S Kutner
Journal:  J Gen Intern Med       Date:  2019-02-04       Impact factor: 5.128

6.  Potentially Avoidable Hospital Readmissions in Patients With Advanced Cancer.

Authors:  P Connor Johnson; Yian Xiao; Risa L Wong; Sara D'Arpino; Samantha M C Moran; Daniel E Lage; Brandon Temel; Margaret Ruddy; Lara N Traeger; Joseph A Greer; Ephraim P Hochberg; Jennifer S Temel; Areej El-Jawahri; Ryan D Nipp
Journal:  J Oncol Pract       Date:  2019-04-04       Impact factor: 3.840

7.  Impact of dyspnea on advanced cancer patients referred to a palliative radiotherapy clinic.

Authors:  Leigha Rowbottom; Stephanie Chan; Liying Zhang; Rachel McDonald; Elizabeth Barnes; May Tsao; Pearl Zaki; Edward Chow
Journal:  Support Care Cancer       Date:  2017-03-24       Impact factor: 3.603

Review 8.  Association Between Palliative Care and Patient and Caregiver Outcomes: A Systematic Review and Meta-analysis.

Authors:  Dio Kavalieratos; Jennifer Corbelli; Di Zhang; J Nicholas Dionne-Odom; Natalie C Ernecoff; Janel Hanmer; Zachariah P Hoydich; Dara Z Ikejiani; Michele Klein-Fedyshin; Camilla Zimmermann; Sally C Morton; Robert M Arnold; Lucas Heller; Yael Schenker
Journal:  JAMA       Date:  2016-11-22       Impact factor: 56.272

9.  Timing of Palliative Care Referral Before and After Evidence from Trials Supporting Early Palliative Care.

Authors:  David Hausner; Colombe Tricou; Jean Mathews; Deepa Wadhwa; Ashley Pope; Nadia Swami; Breffni Hannon; Gary Rodin; Monika K Krzyzanowska; Lisa W Le; Camilla Zimmermann
Journal:  Oncologist       Date:  2021-01-02

10.  Symptoms of posttraumatic stress disorder among hospitalized patients with cancer.

Authors:  Ryan D Nipp; Areej El-Jawahri; Sara M D'Arpino; Andy Chan; Charn-Xin Fuh; P Connor Johnson; Daniel E Lage; Risa L Wong; William F Pirl; Lara Traeger; Barbara J Cashavelly; Vicki A Jackson; David P Ryan; Ephraim P Hochberg; Jennifer S Temel; Joseph A Greer
Journal:  Cancer       Date:  2018-06-15       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.